FDA

FDA Cracks Down on Regenerative and Stem Cell Therapies
FDA Cracks Down on Regenerative and Stem Cell TherapiesNew therapies hold great promise—and great danger.
Ninjacof Recall, Tied to Previous PharmaTech RecallsThe recall is just the latest in a bacterial contamination scare.
Inconsistent Labeling of Sulfites Could Cause HarmA tricky labeling system could be affecting your patients.
Amneal Recalls 13 Lots of Lorazepam Oral
Amneal Recalls 13 Lots of Lorazepam OralThe provided droppers may have been mislabeled.
Pravastatin Bottles Recalled: Actual Content Is BupropionInternational Laboratories recalling one lot of bottles labeled 40-mg pravastatin.
Recall of Not-So-Sterile Drug ProductsFDA is alerting health professionals to a sterility breach with Vital Rx Inc. products.
FDA Recalls All PharmaTech Liquid Drugs
FDA Recalls All PharmaTech Liquid DrugsThe recall affects a variety of distributors.
The FDA Warns Against E-Cigarettes
The FDA Warns Against E-CigarettesA youth education campaign about e-cigarettes is part of FDA’s tobacco/nicotine plan.
Faster Drug Approvals Mean Healthier Patients (Maybe)
Faster Drug Approvals Mean Healthier Patients (Maybe)How the FDA is prioritizing drugs that offer the biggest health gains.
Increased Poison Center Calls Due to Supplements
Increased Poison Center Calls Due to SupplementsA new study shows that supplement exposure rates have been increasing—pharmacists have a responsibility to slow those rates.